# Nexalin Therapy as a Viable Adjunctive Treatment for Substance Use Disorders

> **NCT03540745** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University of Arizona** · enrollment: 14 (actual)

## Conditions studied

- Depression
- Anxiety
- Insomnia
- Substance Abuse

## Interventions

- **DEVICE:** TES Treatment
- **DEVICE:** TES-SHAM Treatment

## Key facts

- **NCT ID:** NCT03540745
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-06-11
- **Primary completion:** 2019-04
- **Final completion:** 2019-11
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2018-10-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03540745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03540745, "Nexalin Therapy as a Viable Adjunctive Treatment for Substance Use Disorders". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03540745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*